The purpose of this step was twofold: on one hand, to verify that the expression of gelsolin was discriminatory and reproducible among BC patients, healthy carriers and controls, and, on the other hand, to verify if those differences were present in undepleted plasma samples. Here, GSN is linked to breast cancer.